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ABSTRACT
While a number of aminoacyl tRNA synthetase
(aaRS):tRNA pairs have been engineered to alter or
expand the genetic code, only the Methanococcus
jannaschii tyrosyl tRNA synthetase and tRNA have
been used extensively in bacteria, limiting the types
and numbers of unnatural amino acids that can be
utilized at any one time to expand the genetic code.
In order to expand the number and type of aaRS/
tRNA pairs available for engineering bacterial
genetic codes, we have developed an orthogonal
tryptophanyl tRNA synthetase and tRNA pair,
derived from Saccharomyces cerevisiae. In the
process of developing an amber suppressor tRNA,
we discovered that the Escherichia coli lysyl tRNA
synthetase was responsible for misacylating the
initial amber suppressor version of the yeast
tryptophanyl tRNA. It was discovered that modifica-
tion of the G:C content of the anticodon stem and
therefore reducing the structural flexibility of this
stem eliminated misacylation by the E. coli lysyl
tRNA synthetase, and led to the development of a
functional, orthogonal suppressor pair that should
prove useful for the incorporation of bulky, unnat-
ural amino acids into the genetic code. Our results
provide insight into the role of tRNA flexibility in
molecular recognition and the engineering and
evolution of tRNA specificity.
INTRODUCTION
Engineering the genetic code has recently emerged as a
method to potentially create novel ‘allo-proteins’ which
could have a myriad of applications in the pharmaceutical
and biotechnology industries as well as serve as novel
components for synthetic biology. To facilitate the
site-speciﬁc incorporation of novel amino acids into
proteins, additional engineered orthogonal aminoacyl
tRNA synthetase (aaRS):tRNA pairs can be expressed
in cells [reviewed in (1,2)]. Orthogonal aaRS–tRNA
pairs frequently take advantage of the cross-species differ-
ences in the recognition elements of aaRSs and their
cognate tRNAs (3), and have utilized nonsense codons
(3) or frameshift codons (4) to expand the canonical
genetic code.
To date, there have been only eight completely unique
orthogonal pairs reported for use in the prokaryotic
(Escherichia coli) translational system. These orthogonal
pairs include the aspartic acid (5), glutamine (6), and
phenylalanine (7) aaRS/tRNA pairs from Saccharomyces
cerevisiae; the glutamic acid pair from Methanosarcina
mazei (8); the leucine pair from Methanobacterium
thermoautotrophicum (9); the lysine pair from Pyrococcus
horikoshii (4); the pyrrolysine pair from Methanosarcinia
barkeri (10); and the tyrosyl pair from Methanococcus
jannaschii (3). However, only the TyrRS-tRNA
Tyr pair
from M. jannaschii has been used extensively to expand
the genetic code of bacteria (2).
The tryptophanyl tRNA synthetase (WRS) is part of
the class Ic subclass of aaRSs that also includes the evo-
lutionarily related tyrosyl tRNA synthetase (11). Based on
the structural and phylogenetic studies of the
tryptophanyl and the tyrosyl tRNA synthetases, it is gen-
erally believed that the WRS was the last synthetase to
evolve (12–14). Both the tyrosyl tRNA and WRSs lack
any sort of an editing domain. Instead, they rely on the
interaction of conserved active site residues to speciﬁcally
recognize and position their substrates into their binding
pockets (15).
The lack of an editing domain in WRS and its capacious
binding pocket for the largest natural amino acid have led
to its use for the incorporation of amino acid analogs into
proteins (16,17). The expanded substrate ﬂexibility of
WRS has even supported adaptive evolution of whole
bacteria and bacteria phage proteomes to tryptophan
analogs (18–20). However, the engineering of the WRS
for the site-speciﬁc insertion of large, unnatural amino
*To whom correspondence should be addressed. Tel: +1 512 471 6445; Fax: +1 512 471 7014; Email: andy.ellington@mail.utexas.edu
Published online 22 June 2010 Nucleic Acids Research, 2010, Vol. 38, No. 19 6813–6830
doi:10.1093/nar/gkq521
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.acids has largely been ignored, especially when compared
with tyrosyl tRNA synthetase (2). Zhang et al. (21) have
used the Bacillus subtilis WRS and an opal suppressor
(anticodon UCA) variant of the B. subtilis tRNA
Trp for
the site-speciﬁc incorporation of 5-hydroxytryptophan
into proteins in mammalian cells, but this orthogonal
pair cannot be used in E. coli since they have overlapping
recognition elements.
Therefore, to further explore the types of unnatural
amino acids that can be site-speciﬁcally encoded in
bacteria and to expand the potential utility of synthetic
orthogonal pairs both in vivo and in vitro, we have
sought to develop a new tryptophanyl orthogonal pair.
The E. coli tRNA
Trp has a major identity element at the
G73 discriminator base and the anticodon CCA
sequence, and additional weak identity elements in the
ﬁrst 3bp of the acceptor stem (22). In contrast, yeast
tRNA
Trp has an adenosine residue at position 73, and
the identity elements in the ﬁrst 3bp of the acceptor stem
also differ from those found in the E. coli tRNA
Trp [(23);
Figure 1A]. Himeno et al. have shown that mutations at
A73 and the G1-C72 base pair of the E. coli tRNA
Trp
that make it more similar to the yeast tRNA
Trp also lead
to inactivity with the E. coli WRS. Moreover, amber
suppressor versions of E. coli tRNA
Trp (anticodon
CUA) lose their ability to be recognized by the E. coli
TrpRS and are instead aminoacylated by the E. coli
GlnRS (24). However, this is not the case for the yeast
tRNA
Trp, which not only maintains its tryptophan
identity in yeast cells but also is an efﬁcient amber sup-
pressor (25,26). Taken together, these results suggest that
it should be possible to develop a new orthogonal pair
for use in E. coli based on the WRS and the amber
suppressor variant of its cognate tRNA from S.
cerevisiae.
MATERIALS AND METHODS
Materials
E. coli strain, CSH108 (Genotype: F0 [F128: LacZ8(Am),
LacI373] (gpt-lac)5, -,ara(FG),gyrA-(NAlR),argE-
(Am),rpoB-(rifR), thi-1) was obtained from the E. coli
Genetic Stock Center (Strain # 8081) http://cgsc.biology
.yale.edu/. Top10 (for routine cloning) and BL21
(DE3)Star chemically competent cells were from
Figure 1. Tryptophan tRNAs and DNA expression constructs. (A) Cloverleaf representations of E. coli tRNA
Trp and S. cerevisiae tRNA
Trp. The
known identity elements for each tRNA are shown in red. (B) Expression construct for ScWRS in plasmids pRS.1 and pRST.11B. (C) Expression
construct for the Sc-tRNA
Trp
Amb and its variants in plasmids pBRIVTC3B and pRST.11B. (D) Plasmid constructs. pRST.11B is the dual tRNA/
aaRS expression vector containing both of the expression constructs shown in (B and C). Plasmid pRS.1 expresses only the ScWRS and is similar to
pRST.11B except that it lacks the tRNA expression construct shown in (B). Plasmid pBRIVTC3B expresses only the tRNA. Plasmid
pACYCSOLO-DHFR V10Amb is the target protein (DHFR) expression vector. The encoded DHFR gene contains an in-frame amber (TAG)
mutation at the 10th amino acid position and a C-terminal HisTag.
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was from VWR Scientiﬁc (West Chester, PA, USA).
All restriction enzymes, T4 DNA ligase and vector
pBR322 were from New England Biolabs (Ipswich, MA,
USA). Vector pACYCDuet-1 was obtained from
Novagen (San Diego, CA, USA). Vector pET28b and
KOD polymerase were from Novagen (Gibbstown, NJ,
USA). Wizard SV Gel and PCR cleanup kit were from
Promega (Madison, WI, USA). Oligonucleotides were
obtained from Integrated DNA Technologies (IDT;
Coralville, IA, USA). The Klenow fragment
polymerase, SimplyBlue Safestain and NuPAGE
4–12% Bis–Tris precast gels were from Invitrogen
(Carlsbad, CA, USA). Quickchange site-directed
mutagensis kits and Pfu polymerase were from
Stratagene (La Jolla, CA, USA).
Protease inhibitor cocktail was from Roche
(Indianapolis, IN, USA). Ni-NTA resin was obtained
from Qiagen (Germantown, MD, USA). The anti-
polyhistidine alkaline phosphatase primary conjugate
antibody was from Sigma-Aldrich (St. Louis, MO,
USA). All buffers and chemicals were obtained from
Sigma-Aldrich (St. Louis, MO, USA) or Fisher Scientiﬁc
(Waltham, MA, USA).
Cloning of the S. cerevisiae WRS gene
The coding sequence for the WRS from S. cerevisiae
(ScWRS) (27) was ampliﬁed using the PCR and the
primers ScWRS.f-3 50-TCGAAAAGCTTCCATGAGCA
ACGACGAAACTGTAGAG-30 (HindIII), ScWRS.r-3
50-GCAGCCTCGAGTTACTTCTTTTCTTGCTTAGT
TTTTGGC-30 (XhoI) from a glass-bead lysed yeast cell
extract. The restriction sites introduced are underlined and
speciﬁed in parentheses. The resulting approximately
1.3kb PCR product was digested with XhoI and
HindIII and ligated into a similarly digested pET-28b
vector using T4 DNA ligase following the conditions rec-
ommended by the enzyme supplier. The ligation mixture
was transformed into Top10 cells and the resulting kana-
mycin resistant-colonies were screened via colony PCR for
the ScWRS insert. Positive clones were veriﬁed by DNA
sequencing from puriﬁed clonal plasmids using the
primers T7 Terminator Primer 50-GCTAGTTATTGCTC
AGCGG-30 and T7 Promoter Primer 50-TAATACGACT
CACTATAGGG-30. The resulting sequence-conﬁrmed
plasmid was termed pET28b-ScWRS. This expression
vector expresses ScWRS from the T7 promoter with an
N-terminal His-tag.
Design and construction of the pRS.1 tRNA
synthetase expression vector
In order to express the ScWRS gene in E. coli, the expres-
sion construct (module) shown in Figure 1B was con-
structed. This expression construct was designed to be
modular in that different components of the construct
could be replaced using unique restriction sites ﬂanking
each of the three portions of the construct (i.e.
promoter-RBS, aaRS, transcription terminator). For
example, the gene for the ScWRS shown in green in
Figure1B could be replaced by restriction digestion with
XbaI and XhoI. Since successful nonsense suppression is
the result of an acylated suppressor tRNA successfully
competing with endogenous release factors for termin-
ation codons, maintenance of high levels of acylated sup-
pressor tRNAs within the cell is important, therefore we
expressed ScWRS from the strong, synthetic tacI
promoter (28) and the strong Shine Dalgarno sequence
(AAGGAG) from the expression vector pET14b.
Transcription termination was mediated by the
luxICDABEG terminator sequence (Biobrick part:
BBa_B0021) obtained from the Biobrick parts registry at
MIT (http://partsregistry.org/Main_Page). The overall
construct was assembled by overlap extension PCR.
The plasmid construct for expressing the ScWRS is
shown in Figure 1D. The aforementioned synthetase ex-
pression construct was cloned into the HindIII and EagI
sites of pBR322 to yield the vector pRS-ScWRS. This
cloning step removes the majority of the tetracycline re-
sistance element found in pBR322, but leaves the ampicil-
lin resistance element. This vector contains the ColE1
origin of replication which maintains the plasmid at
15–30 copies per cell (29). To help regulate the expression
of the ScWRS from the strong tacI promoter, the expres-
sion sequence for LacIq was cloned into the ZraI and
HindIII sites of this vector to yield vector pRS.1. The
IPTG-induced expression of the ScWRS gene from this
plasmid was veriﬁed by a western blot assay by probing
for the C-terminal His-Tag in a His tagged version
of ScWRS (in vector pRS.1ht) using an alkaline phosphat-
ase conjugated anti-polyhistidine antibody (Sigma-
Aldrich; St. Louis, MO, USA). As can be seen from
Supplementary Figure S1, the ScWRS is efﬁciently ex-
pressed from this construct, though some aggregation in
the pellet occurs due to overexpression. A more detailed
description of the construction of pRS.1 and related
vectors can be found in the Supplementary Data.
Design and construction of the IVTC3 tRNA
expression plasmids
To express the yeast tRNA
Trp amber suppressor, the syn-
thetic construct shown in Figure 1C was designed and
built from overlapping oligonucleotides. This synthetic
construct expresses the tRNA under the control of the
tRNA leuV 50-UTR (region from  112 to +33), which
contains the stable RNA promoter  35 and  10 regions
and an upstream FIS element (30,31). The FIS element
was included in the 50-UTR as it is known to enhance
transcription initiation from this promoter (32). In
addition, the+1 to+33 sequences from the leuV 50-UTR
was maintained as it contains the natural tRNA process-
ing sequence. The tRNA sequence is ﬂanked by unique
KpnI and BsrGI sites to facilitate cloning of different
tRNA sequences into the expression construct.
Transcription termination is carried out by the rho inde-
pendent terminator contained in the argT 30-UTR (33).
This construct was cloned into vector pBR322 or vector
pRS.1 to yield the tRNA expression vectors pBRIVTC3
and pRST.11, respectively (Figure 1D). The expression
and maturation of the yeast tRNA
Trp amber suppressor
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northern blotting with a Sc-tRNA
Trp-speciﬁc DNA oligo-
nucleotide probe (Supplementary Figure S2). While the
recombinant Sc-tRNA
Trp
Amb was cleaved from the ex-
pressed pre-tRNA transcript at sufﬁcient levels
( 20-30%) to observe nonsense suppression in vivo,
future improvements to the processing efﬁciency of
tRNAs expressed from this construct could lead to
increased nonsense suppression efﬁciency in vivo.A
thorough description of the design, construction and
assay of these constructs and vectors can be found in the
Supplementary Data.
Construction of vector pACYCSolo
Vector pACYCDuet-1 was digested with EcoNI and
BsrGI to remove the MCS1 and redundant T7promoter.
The double-digested plasmid band was gel-puriﬁed from a
low-melt agarose gel using the Promega (Madison, WI,
USA) PCR and gel puriﬁcation kit. The linearized
vector was ‘blunted’ by reaction with the Klenow
fragment polymerase using the following conditions:
linearized plasmid, 0.5mM each dNTP, 1 React2
Buffer (Klenow reaction buffer, supplied with enzyme)
and 1.5U Klenow fragment. The elongation reaction
was carried out at room temperature for 30min,
followed by agarose gel puriﬁcation. The blunted vector
was closed with T4 DNA ligase under the following con-
ditions: linearized vector, 1 T4 DNA ligase buffer
(50mM Tris pH 7.5, 10mM MgCl2, 10mM DTT, 1mM
ATP) and 20 U T4 DNA ligase. The ligation mixture was
transformed into Top10 cells and colonies were screened
via colony PCR using the primers pACYCDuet-f and
pACYCDuet-r. Plasmids that appeared to contain the
correct insert were submitted for sequencing at the
ICMB DNA Core Facility. The sequence veriﬁed vector
was named pACYCSolo. This vector contained a multiple
cloning site sequence ﬂanked by the T7lac promoter and a
transcription terminator. It also contained the coding se-
quences for the Lac repressor and chloramphenicol acetyl
transferase. This vector is a pACYC184 derivative and
contains the P15A origin which is compatible with other
vectors containing ColE1 origins.
Construction of vectors pACYCSolo-DHFR and
pACYCSolo-DHFR_V10Amb
The coding sequence for E. coli dihydrofolate reductase
(DHFR) and DHFR_V10Amb was ampliﬁed from the
plasmids pIVEX1.4WG-DHFR or pIVEX1.4WG-
DHFR_V10Amb (R. A. Hughes and A. D. Ellington,
unpublished results), respectively, with primers DHFR-
pivex1.4-f-1 50-GTTACTTTCACATATGATCAGTCTG
ATTGCGGCGTTAGC (NdeI), DHFR-HIS6-r 50-GCT
GCTCGAGTTAATGATGATGATGATGATGGCTGC
CCCGCCGCTCCAGAATCTC-30(XhoI). The restriction
sites used for cloning are underlined. The ﬂanking primer,
DHFR-His6-r, encoded a C-terminal His-tag (amino acid
sequence GSGHHHHHH). The ampliﬁed genes were
digested with NdeI and XhoI and cloned into similarly
digested pACYCSolo. Cloned sequences were screened
by colony PCR for insertion of the gene sequence and
veriﬁed by sequencing with primers pACYCDuet-f 50-TT
GCGCCATTCGATGGTGTC and pACYCDuet-r 50-AA
AACCCCTCAAGACCCGTT. Sequence veriﬁed clones
were designated pACYCSolo-DHFR and pACYCSolo-
DHFR_V10 (Figure 1D) for the expression constructs
containing C-terminal His-tagged DHFR and
DHFR_V10Amb, respectively.
DHFR nonsense suppression assay
Plasmids pBRIVTC3B and pRST.11B containing
Sc-tRNA
Trp
Amb or both ScWRS and Sc-tRNA
Trp
Amb,
respectively, were co-expressed with pACYCSolo-
DHFR_V10Amb in BL21(DE3) or BL21(DE3)Star cells.
A control strain containing pACYCSolo-DHFR_
V10Amb and pBR322, which lacks both ScWRS and
Sc-tRNA
Trp
Amb, was used to determine background sup-
pression rates. The strains containing these plasmids were
grown in Terriﬁc Broth at 37 Ct oO D 600  0.7–0.8 at
which point the expression of DHFR and ScWRS was
induced by the addition of IPTG to 1mM. Cells were
grown overnight at 37 or 30 C. Following induction and
co-expression, the cells were collected by centrifugation
and resuspended in binding buffer (50mM Tris, pH 8.0,
0.5M NaCl, 5mM imidazole) containing 1 protease in-
hibitor cocktail and 1mg/ml lysozyme. The resuspended
cells were lysed by sonication on ice using 30% probe
amplitude and ﬁve pulse cycles (30s ON, 15s OFF).
Following sonication, the cell debris was pelleted via cen-
trifugation at 10000g for 20min. The cleared lysate was
transferred to a new centrifuge tube and centrifuged again
at 11000g for 15min to remove any remaining insoluble
material.
The His-tagged DHFR was puriﬁed via immobilized
metal afﬁnity chromatography (IMAC) (34). The cleared
lysate was applied to a 1ml (bead volume) Ni-NTA
gravity column pre-incubated with 4 column volumes
of binding buffer and allowed to enter the column by
gravity ﬂow. The column was washed once with
10 column volumes of Binding Buffer, once with
3 column volumes of Wash Buffer 1 (50mM Tris, pH
8.0, 0.5M NaCl, 20mM imidazole) and once with
3 column volumes of Wash Buffer 2 (50mM Tris, pH
8.0, 0.5M NaCl, 30mM imidazole). DHFR-His6 was
eluted from the Ni-NTA column by the addition of
4 column volumes of Elution Buffer (50mM Tris, pH
8.0, 0.5M NaCl, 250mM imidazole). Protein fractions
were analyzed by SDS–PAGE on a 4–12% Bis–Tris
NuPAGE developed in MES SDS buffer (50mM MES
pH 7.3, 50mM Tris, 3.5mM SDS, 1mM EDTA) under
reduced, denaturing conditions and stained using
SimplyBlue Safestain. Each fraction was normalized to
the wet cell pellet weight prior to loading on the gel.
Puriﬁed proteins were quantitated using a modiﬁed
Bradford Assay (Bio-Rad; Hercules, CA, USA).
Edman N-terminal protein sequencing
Proteins (usually  300pmol) to be sequenced were
separated on a 4–12% NuPAGE Bis–Tris gradient gels
in MES SDS buffer and transferred to a Polyvinylidene
ﬂuoride (PVDF) membrane using the Bio-Rad semidry
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NuPAGE transfer buffer (25mM Bis–Tris, pH7.2,
25mM Bicine, 1mM EDTA, 2mM DTT, 20%
methanol). The transfer was performed at 25V for 1h.
Following transfer, the membrane was washed with
HPLC grade water containing 2.5mM DTT for 2min.
The membrane was then stained in 0.1% Coomassie
Blue + 2mM DTT until the protein bands were visible.
The membrane was destained via multiple washes in 50%
methanol, 10% acetic acid, and 1mM DTT. The destained
membrane was washed in HPLC grade water containing
1mM DTT for 5–10min. Destained blots were submitted
to the Protein Core Facility (Institute for Cellular and
Molecular Biology, The University of Texas at Austin)
where the ﬁrst 15–20 amino acids of the membrane-bound
18kDa DHFR band were excised and sequenced accord-
ing to Edman degradation protocols on an Applied
Biosystems model 477 protein sequencer (ABI; Carlsbad,
CA, USA). Sequenced amino acids were identiﬁed and
quantitated using reference standards. Identiﬁcation of
the amino acid substituted at amber codon 10 of the
modiﬁed DHFR protein was done by subtractive com-
parison of the chromatographs produced for position 9
from those produced at position 10. The identity of the
amino acid incorporated at position 10 within DHFR was
deﬁned as the most abundant (in pmol) amino acid in the
subtracted spectrum.
Construction and cloning of Sc-tRNA
Trp variants
All of the tRNA gene sequences were designed to be cloned
between the KpnI and BsrGI sites of the tRNA expression
cassette in vectors pBRIVTC3B and pRST.11B. The con-
structs contained tRNA processing sequences (following
the KpnI site and preceding the BsrGI site).
The construct sequences were assembled from four
overlapping oligonucleotides according to the gene
assembly PCR procedure developed by Stemmer (35).
The component  60nt oligonucleotides were designed
using DNAWorks software (available at: http://
helixweb.nih.gov/dnaworks/) (36). The oligonucleotides
necessary to assemble the tRNA sequences are shown
in Table 1. Each tRNA variant was assembled from four
overlapping oligonucleotides (numbered XXX.1–XXX.4).
The oligonucleotides were resuspended in sterilized water
to a ﬁnal concentration of 250mM, and were mixed
together to give a 2.5mM oligonucleotide mixture of
each oligonucleotide. An initial assembly PCR was
carried out under the following conditions: 1ml 2.5mM
oligo mix, 5ml1 0  PfuTurbo buffer, 2.5ml 4mM dNTP
mix, 1ml Pfu polymerase (added after an initial denatur-
ation step) and water to 50ml total volume. The assembly
reactions were thermally cycled under the following
regime: (1) 95 C-5min, (2) 95 C-30sec, (3) 50 C-30sec,
(4) 72 C-60sec, (5) Go to step (2) 25 times and
(6) 72 C-10min. Full-length genes were subsequently
ampliﬁed by PCR: 1mM assembly PCR, 5ml
10 PfuTurbo buffer, 2.5ml 4mM dNTP mix, 1mlo f
each ﬂanking primer (20mM; Table 1), 1ml Pfu polymerase
(added after an initial denaturation step) and water to
50ml total volume. The ampliﬁcation reactions were
thermally cycled: (1) 95 C-5min, (2) 95 C-30sec,
(3) 62 C-30sec, (4) 72 C-60sec, (5) Go to step (2)
25 times and (6) 72 C-10min. The ﬁnal PCR was
separated on agarose gels to verify the presence of
full-length product.
The assembled tRNA constructs were digested with
KpnI and BsrGI and ligated into similarly digested
pBRIVTC3B and pRST.11B with T4 DNA ligase.
Clones were screened via colony PCR and sequences
were conﬁrmed by sequencing with primers pRS1871-94
50-AACCCTTGGCAGAACATATCCATC-30 or
pRS2022-47r 50-CTCGCGTATCGGTGATTCATTCTG
CT-30. Plasmids containing the tRNA variants are
designated by the following nomenclature: plasmid
name-tRNA variant (i.e. pBRIVTC3B-AS3.4).
b-galactosidase colony spot assay
Plasmids pBRIVTC3B (tRNA only) and pRST.11B
(ScWRS and tRNA) containing Sc-tRNA
Trp
Amb vari-
ants were transformed into strain CSH108 via electropor-
ation. Transformed colonies were picked and suspended
in 10ml of LB broth. Two microliter aliquots of this
mixture were spotted in triplicate onto LB agar plates con-
taining 50mg/mL ampicillin, 1mM IPTG and 0.2mg/mL
X-gal. The spotted plates were incubated at 37 C
overnight.
LB broth cultures (3ml) containing 50mg/ml ampicillin
and 1mM IPTG were also inoculated (10ml) and grown
overnight at 37 C. Some 2ml of each of the cultures was
spun down and the cells lysed in 300ml of B-PER reagent
containing 1 protease inhibitor and 200mg/ml lysozyme.
The cell debris was removed by centrifugation at 15000g
for 15min. The protein concentration in the lysate
was determined using a modiﬁed Bradford Assay. The
b-galactosidase activity in the lysate samples was assayed
using the high sensitivity b-galactosidase assay kit
from Stratagene (Cedar Creek, TX, USA). Triplicate
samples from each culture were measured by optical ab-
sorbance (at 570nm) of the chromogenic product,
chlorophenol red.
RESULTS
Assaying the functionality of the
ScWRS/Sc-tRNA
Trp
Amb pair
In order to test the functionality of the ScWRS/
Sc-tRNA
Trp
Amb pair, the plasmids pBRIVTC3B, pRS.1
and pRST.11B which express only the Sc-tRNA
Trp
Amb,
only the ScWRS or both the ScWRS and
Sc-tRNA
Trp
Amb together, respectively, were transformed
into E. coli strain CSH108. This strain contains an
episomal lacZ gene with an amber nonsense codon
(TAG) in a position that has previously been shown to
be tolerant of a variety of amino acid substitutions. If a
suppressor tRNA is active in vivo, then full-length
b-galactosidase should be produced resulting in a blue-
colored colony upon cleavage of the galactoside analog,
5-bromo-4-chloro-3-indoyl-b-D-galactopyranoside (X-gal).
A translationally inactive suppressor or an orthogonal
suppressor in the absence of its cognate aaRS will yield
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termination.
As can be seen in Figure 2, when the ScWRS/
tRNA
Trp
Amb pair was expressed in CSH108, a blue
colony was formed, indicating that the heterologous
yeast suppressor tRNA was active in the bacterial trans-
lational system. However, a blue colony was also obtained
when the Sc-tRNA
Trp
Amb was expressed by itself in
CSH108, indicating that this tRNA was not completely
orthogonal to the set of E. coli tRNA synthetases. That
said, when these strains were grown in solution, the
tryptophanyl pair produced 66 Miller units of
b-galactosidase per milligram of total protein (U/mg),
whereas the strain carrying only Sc-tRNA
Trp
Amb
suppressor produced 21U/mg of enzyme. While it was
likely that the ScWRS was being expressed in an active
form and was able to aminoacylate its cognate suppressor
tRNA in E. coli, the background aminoacylation activity
of the Sc-tRNA
Trp
Amb required additional modiﬁcation in
order to create an orthogonal suppressor.
Identifying background mischarging
To determine which aaRS was responsible for
misacylating the yeast tryptophanyl suppressor tRNA
(Sc-tRNA
Trp
Amb), the plasmid pBRIVTC3B that
expresses the Sc-tRNA
Trp
Amb was co-transformed with
pACYCSolo-DHFR_V10Amb, a plasmid that expresses
Table 1. Oligonucleotides used to construct suppressor tRNAs
Oligonucleotide name Sequence (50–30)
RH-ScWA_U30G40.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGGC
RH-ScWA_U30G40.2 CCTGCAACCCTTCCATTTAGAGTAGAAAGCTCTACCATTGAGCCACCGCTTCATACCATC
RH-ScWA_U30G40.3 TCTAAATGGAAGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCTT
RH-ScWA_U30G40.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGT
RH-ScWA_C70.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGG
RH-ScWA_C70.2 GCAACCCTTCGATTTAGAGTCGAAAGCTCTACCATTGAGCCACCGCTTCATACCATCAAT
RH-ScWA_C70.3 GACTCTAAATCGAAGGGTTGCAGGTTCAATTCCTGTCCGCTTCACCAATTTTGAACCCCG
RH-ScWA_C70.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGTGAAG
RH-ScWA_C70U30G40.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGGC
RH-ScWA_C70U30G40.2 CCTGCAACCCTTCCATTTAGAGTAGAAAGCTCTACCATTGAGCCACCGCTTCATACCATC
RH-ScWA_C70U30G40.3 TCTAAATGGAAGGGTTGCAGGTTCAATTCCTGTCCGCTTCACCAATTTTGAACCCCGCTT
RH-ScWA_C70U30G40.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGT
RH-ScWA_AS1.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGGC
RH-ScWA_AS1.2 ACCTGCAACCCGCCGGTTTAGAGCCGGCAGCTCTACCATTGAGCCACCGCTTCATACCAT
RH-ScWA_AS1.3 CGGCGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCTTCGGCGGG
RH-ScWA_AS1.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGG
RH-ScWA_AS2.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTG
RH-ScWA_AS2.2 CAACCCCGCGCTTTAGAGGCGCGAGCTCTACCATTGAGCCACCGCTTCATACCATCAATT
RH-ScWA_AS2.3 CTCTAAAGCGCGGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCT
RH-ScWA_AS2.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGT
RH-ScWA_C70AS1.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGGC
RH-ScWA_C70AS1.2 ACCTGCAACCCGCCGGTTTAGAGCCGGCAGCTCTACCATTGAGCCACCGCTTCATACCAT
RH-ScWA_C70AS1.3 CGGCGGGTTGCAGGTTCAATTCCTGTCCGCTTCACCAATTTTGAACCCCGCTTCGGCGGG
RH-ScWA_C70AS1.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGG
RH-ScWA_C70AS2.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGG
RH-ScWA_C70AS2.2 CCGCGCTTTAGAGGCGCGAGCTCTACCATTGAGCCACCGCTTCATACCATCAATTCTTAA
RH-ScWA_C70AS2.3 CGCCTCTAAAGCGCGGGGTTGCAGGTTCAATTCCTGTCCGCTTCACCAATTTTGAACCCC
RH-ScWA_C70AS2.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGTGAAGC
RH-ScWA_AS3.1 TAGAGCTGCCGCCTCTAAAGCGGCGGGTTGC
RH-ScWA_AS3.2 GCAACCCGCCGCTTTAGAGGCGGCAGCTCTA
RH-ScWA_AS3.2.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGG
RH-ScWA_AS3.2.2 TGCAACCCGGCGGTTTAGAGCCGCCAGCTCTACCATTGAGCCACCGCTTCATACCATCAA
RH-ScWA_AS3.2.3 AACCGCCGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCTTCGGC
RH-ScWA_AS3.2.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCA
RH-ScWA_AS3.3.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGG
RH-ScWA_AS3.3.2 TGCAACCCCCCGGTTTAGAGCCGGGAGCTCTACCATTGAGCCACCGCTTCATACCATCAA
RH-ScWA_AS3.3.3 TAAACCGGGGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCTTCG
RH-ScWA_AS3.3.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTG
RH-ScWA_AS3.4.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTGG
RH-ScWA_AS3.4.2 TGCAACCCGGCGCTTTAGAGGCGCCAGCTCTACCATTGAGCCACCGCTTCATACCATCAA
RH-ScWA_AS3.4.3 AAGCGCCGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCTTCGGC
RH-ScWA_AS3.4.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCA
RH-ScWA_AS3.5.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTG
RH-ScWA_AS3.5.2 CAACCCCCCGCTTTAGAGGCGGGAGCTCTACCATTGAGCCACCGCTTCATACCATCAATT
RH-ScWA_AS3.5.3 CTCTAAAGCGGGGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCT
RH-ScWA_AS3.5.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGT
RH-ScWA_AS3.6.1 GCGCCTCCGTGGTACCAATTCTTTTTAAGAATTGATGGTATGAAGCGGTG
RH-ScWA_AS3.6.2 CAACCCCGCGGTTTAGAGCCGCGAGCTCTACCATTGAGCCACCGCTTCATACCATCAATT
RH-ScWA_AS3.6.3 CTCTAAACCGCGGGGTTGCAGGTTCAATTCCTGTCCGTTTCACCAATTTTGAACCCCGCT
RH-ScWA_AS3.6.4 GTGACGAAATGTACAGAAAACAAAAAACCCCGCCGAAGCGGGGTTCAAAATTGGT
6818 Nucleic Acids Research, 2010, Vol.38, No. 19the protein DHFR. The DHFR protein sequence contains
an amber nonsense codon (TAG) at amino acid position
10 (V10Amber). Therefore, only in the presence of an
amber suppressor tRNA is full-length DHFR translated
(Figure 3A). Expression of the pACYCSolo-DHFR_
V10Amb plasmid in the absence of the Sc-tRNA
Trp
Amb
suppressor does not yield any DHFR as determined by
a Commassie stained SDS–PAGE gel (control ( )
bands, Figure 3B). The DHFR expressed in the presence
of the suppressor was puriﬁed via its C-terminal HisTag
and submitted for N-terminal Edman peptide sequencing
(37). As can be seen in Figure 3C, the Sc-tRNA
Trp
Amb
suppressor mediated the incorporation of lysine (K) at
position 10 of DHFR. Indicating that the
Sc-tRNA
Trp
Amb was being misacylated by the E. coli
lysine tRNA synthetase (EcKRS) when expressed alone
in E. coli. In contrast, when pACYCSolo-DHFR_
V10Amb was co-transformed with plasmid, pRST.11B,
which expresses both the ScWRS and the
Sc-tRNA
Trp
Amb suppressor DHFR contained primarily
tryptophan at position 10 of DHFR (Figure 3D), again
conﬁrming the activity of ScWRS in E. coli.
As was the case with b-galactosidase assay, when the
strains were grown in solution the suppressor tRNA led to
tryptophan being incorporated preferentially to lysine
(actually exclusively, within limits of detection for the
assay). The ScWRS/Sc-tRNA
Trp
Amb pair produced 138
milligrams of DHFR per liter of bacterial culture (mg/l),
versus 14mg/l for the Sc-tRNA
Trp
Amb suppressor alone
and 418mg/l in the absence of the stop codon. Thus, the
suppression efﬁciency of the ScWRS/Sc-tRNA
Trp
Amb pair
can be estimated to be about 33% versus 3% for the
Sc-tRNA
Trp
Amb alone. The greater discrimination
against lysine in the DHFR expression assay relative to
the b-galactosidase expression assay may be due to the
fact that protein expression alone was monitored, as
opposed to enzymatic activity.
Rational design of an orthogonal tRNA
Trp
amber suppressor
Since the EcKRS was determined to be responsible
for causing the background aminoacylation of the
Sc-tRNA
Trp
Amb, we compared the Sc-tRNA
Trp
Amb and
the E. coli tRNA
Lys (Ec-tRNA
Lys) sequences to determine
what features these tRNAs might have in common.
Figure 4 shows the cloverleaf secondary structure of
both tRNAs with conserved residues colored in green
(identical between Ec-tRNA
Lys and Sc-tRNA
Trp
Amb)
or blue (universally conserved amongst tRNAs).
Surprisingly, the yeast tRNA
Trp
Amb suppressor shares
73% sequence identity with the Ec-tRNA
Lys. More im-
portantly, Sc-tRNA
Trp
Amb shares several key lysyl
identity determinants with the Ec- tRNA
Lys. In particular,
the A73 discriminator base is a major identity element for
both the EcKRS (38,39) and the S. cerevisiae WRS (40).
In addition to this discriminator base, the anticodon
sequence UUU for Ec-tRNA
Lys (38,39) and CCA for
Sc-tRNA
Trp (23) are important identity elements for
recognition by their cognate aaRSs. In the case of the
yeast amber suppressor Sc-tRNA
Trp
Amb, since the CCA
anticodon sequence has been changed to CUA, the
critical lysine identity element U35 (39) is inadvertently
added to the anticodon sequence of the suppressor
tRNA. While the U34 anticodon base in Ec-tRNA
Lys
is normally modiﬁed to 5-[(methylamino)-methyl]-
2-thiouridine (mnm
5s
2U) to help read the rare AAG
lysine codon (since E. coli lacks an isoacceptor with a
CUU anticodon), the C34 in the amber suppressor is
accommodated equally well (41).
The fact that the CUA amber suppressor anticodon in
Sc-tRNA
Trp
Amb is cross-reactive is not unique. In fact, the
importance of the A73 discriminator and U35 anticodon
bases for lysine recognition leads amber suppressor
tRNAs derived from yeast tRNAs for the other
Figure 2. LacZ suppression assay with Sc-tRNA
Trp
amb. (A) b-galactosidase suppression assay for ScWRS/tRNA
Trp
Amb pair activity. Triplicate spots
from the same initial culture are shown in column orientation. Cultures transformed with (+) or without ( ) the Sc-tRNA
Trp
Amb or ScWRS are
shown in the right panel. The ( ) negative control culture represents the background level of b-galactosidase activity in the absence of a suppressor
tRNA. The (+) control represents b-galactosidase activity in the presence of a known amber suppressor tRNA [SupF, (Ec-tRNA
Tyr
Amb)] which is
expressed from the pBRIVTC3B plasmid similar to the experimental suppressor tRNAs. (B) Quantitation of b-galactosidase activity produced by the
suppression assay shown in A. pRS.1 expresses just the ScWRS, pRST.11B expresses the ScWRS/tRNA
Trp
Amb pair and pBRIVTC3B expresses just
the Sc-tRNA
Trp
Amb suppressor. Error bars represent 1 SD (n=3).
Nucleic Acids Research, 2010, Vol.38, No. 19 6819Figure 3. DHFR suppression assay. (A) The gene for DHFR containing a V10Amber mutation on plasmid pACYCSolo-DHFR_V10Amb produces
full-length protein when a functional nonsense suppressor is co-expressed with it. (B) Coomassie stained SDS–PAGE gel showing puriﬁcation
fractions from an immobilized nickel chromatography column for DHFR_V10Amb expressed without Sc-tRNA
Trp
Amb or ScWRS ( ) with
Sc-tRNA
Trp
Amb only (tRNAamb) or with both ScWRS and Sc-tRNA
Trp
Amb (RS +tRNAamb). M=marker, W=wash fractions and E=elution
fractions. Full length DHFR appears as an 18kDa protein band. (C) N-terminal sequencing results for DHFR position 10 from a culture containing
pBRIVTC3B (Sc-tRNA
Trp
Amb only). The bar graph represents the detected chromatographic amino acid abundances for position 10 of DHFR
minus those from position 9. Positive abundance represents occupation at position 10 of the DHFR sample, whereas the negatively abundant peaks
are carried over from the previous round of sequencing (position 9). (D) N-terminal sequencing results for DHFR position 10 from a culture
containing pRST.11B (ScWRS and Sc-tRNA
Trp
Amb). The yields of puriﬁed DHFR produced via suppression of the V10Amber codon are given for
each sample.
Figure 4. Comparing Sc-tRNA
Trp
Amb and Ec-tRNA
Lys
UUU. Cloverleaf structures of both tRNAs showing the universally conserved residues in blue
and residues conserved between the two tRNAs in green, for a total of 73% sequence identity overall.
6820 Nucleic Acids Research, 2010, Vol.38, No. 19aromatic amino acids (Phe, Tyr) to be cross-reactive to the
EcKRS in vivo (42,43). These tRNAs also all share a
common G-C base pair between positions 1 and 72 in
the acceptor stem, and an anticodon loop sequence that
is similar to that of Ec-tRNA
Lys.
Since the anticodon loop and the 1–72 base pair se-
quences are required for translation activity in most
tRNAs, it is unlikely that they can be altered in order to
enhance discrimination and orthogonality between the
Sc-tRNA
Trp
Amb and Ec-tRNA
Lys
UUU. Instead, it has pre-
viously been hypothesized that cross recognition may also
be due to the structural plasticity of amber suppressor
tRNAs to adapt to the KRS binding site (44). A number
of facts support this hypothesis. While the crystal struc-
ture of the KRS–tRNA
Lys complex has not been
determined in its entirety, the anticodon binding domain
has been studied in some detail (41,45–47). These struc-
tural and biochemical analyses of KRS reveals that it
undergoes a dramatic change in conformation upon
binding lysine as well as upon the formation of the
Lys-AMP adenylate (41,48). Recently, it has been shown
that the anticodon binding domain of KRS can enhance
the binding efﬁciency of the lysyl-adenylate in the active
site (49).
The hypothesis that the amber suppressor may be
ﬂexible enough to be charged by lysyl tRNA synthetase
in turn suggests how the suppressor might be rationally
engineered to avoid cross-reaction. The anticodon stem of
both the E. coli lysine tRNA and the yeast suppressor
tRNA share a relatively A-U rich (3/5bp) stem
sequence. Indeed, the Ec-tRNA
Lys has only one G-C
pair (G30-C40) in the anticodon stem, while most E. coli
tRNA sequences contain three or more G-C pairs in this
stem. We therefore hypothesized that ‘stiffening’ the anti-
codon stem of the suppressor by making it more G-C rich
should lead to a reduction in background aminoacylation
by EcKRS. This hypothesis was further supported by
the fact that most of the known orthogonal suppressors
in E. coli have relatively G-C rich anticodon stems
(Supplementary Figure S3) and that Fukunaga et al.
(43) have reported that the misacylation of the
Sc-tRNA
Tyr amber suppressor by the EcKRS can also
be reduced by G-C enrichment of the anticodon stem.
Other substitutions have also been shown to reduce
background charging by EcKRS. A U30-G40 wobble
pair has previously been shown to eliminate the cross re-
activity of the EcKRS with the yeast tRNA
Ile amber sup-
pressor (50). This same negative discriminator was also
inserted into the anticodon stem of the Sc-tRNA
Phe
amber suppressor which led to a reduction in the back-
ground misacylation caused by the EcKRS (7).
Based on this analysis, parallel paths were devised to
eliminate the EcKRS-catalyzed background misacylation
of Sc-tRNA
Trp. First, we constructed G-C rich anticodon
stem variants of Sc-tRNA
Trp (Figure 5, Round 1
Mutants). Secondly, we introduced the negative identity
determinant U30-G40 wobble pair into the anticodon
stem of Sc-tRNA
Trp. Finally, a U69C substitution was
introduced into the acceptor stem, since replacement of
a similar wobble pair (U4-G69) in yeast tRNA
Tyr had
previously been shown to increase the suppression
activity of this tRNA. Combinations of these changes
were also generated.
These suppressor variants were assayed either alone or
in combination with the U69C substitution in the acceptor
stem (Figure 6). The suppressor tRNA variants were
Figure 5. Rational Sc-tRNA
Trp
CUA mutants. Designed anticodon stem sequences are shown. The ﬁrst round of mutations from the original sup-
pressor tRNA are shown in red. The anticodon stem mutants were also made in combination with the U69C mutation. The second round anticodon
stem mutations that differ from the ﬁrst set of suppressor designs are shown in cyan. Mutations preserved from the ﬁrst round are shown in red.
Unchanged nucleotides from the original suppressor tRNA are in black.
Nucleic Acids Research, 2010, Vol.38, No. 19 6821cloned into the pBRIVTC3B or pRST.11B expression
vectors and transformed into E. coli strain CSH108 with
or without the cognate ScWRS. Speciﬁc suppression of the
amber nonsense mutation in the b-galactosidase gene by
strains containing the ScWRS/Sc-tRNA
Trp
Amb pair was
compared with background suppression from the strains
only containing the suppressor tRNA variants (Figure 6).
The AS.1 variant shows no suppression activity with or
without the ScWRS. The U30G40 substitution not only
had greatly reduced activity with ScWRS but also showed
no background suppression activity. The AS.2 variant
shows roughly equivalent suppression activity to its
parent, but had 13-fold reduced background suppression
activity (Figure 6).
Figure 6. Suppression activity of rational suppressor tRNA mutants. (A) Structures of tRNA mutants anticodon stems. Sequence changes from
Sc-tRNA
Trp
Amb are denoted by red circles. (B) b-galactosidase colony spot activity assay. Each mutant tRNA was expressed with (+) or without ( )
the ScWRS to test for orthogonality. Each sample was taken from the same culture and spotted in triplicate in column format. (C) Quantitation of
suppression activity with b-galactosidase. Error bars represent 1 SD (n=3).
6822 Nucleic Acids Research, 2010, Vol.38, No. 19Interestingly, all of the variants that contained the
U69C substitution in the acceptor stem showed increased
background suppression relative to the original
Sc-tRNA
Trp
Amb suppressor. N-terminal sequencing of
the DHFR protein produced from the DHFR_V10amb
construct co-expressed with this suppressor revealed that
the U69C substitution changes the identity of the
Sc-tRNA
Trp suppressor from tryptophan to histidine
(data not shown). Therefore, the G4-C69 base pair
introduced by this substitution appears to be a heretofore
unknown identity element for the E. coli histidine tRNA
synthetase (EcHRS) and when combined with the known
G1-C72 and A73 identity elements that are also fortuit-
ously in Sc-tRNA
Trp leads to efﬁcient aminoacylation
by EcHRS.
Optimization of an orthogonal tRNA
Trp amber suppressor
Since initial results indicated that ‘stiffening’ the anti-
codon stem yielded improved suppressor function, each
of the A-U base pairs in the original tRNA anticodon
stem was systematically replaced with G-C base pairs
(Figure 5, Round 2 Mutants). In addition, since the
U30G40 variant eliminated background activity this sub-
stitution was also combined with G-C base pairs
(Figure 5, Round 2 Mutants). These variants were again
screened in the presence and absence of ScWRS
(Figure 7).
The G-C replacements showed a range of activities with
and without the ScWRS. Variant AS3.1 was translation-
ally inactive, whereas variants AS3.2, AS3.3 and AS3.6
were active yet still showed signiﬁcant background sup-
pression activity. However, variants AS3.4 and AS3.5
showed a marked reduction in background suppression
activity while maintaining activity in the presence of
ScWRS. AS3.4 reduced background activity by 28-fold
over the original Sc-tRNA
Trp suppressor, while AS3.5
showed a reduction of nearly 50-fold over the
Sc-tRNA
Trp suppressor. All of the variants containing
U30G40 were either inactive or showed residual back-
ground activity.
Verifying the orthogonality of suppressors AS3.4
and AS3.5
To verify the orthogonality of the two promising suppres-
sor candidates (AS3.4, AS3.5) from the LacZ screen, these
suppressors were co-expressed with and without the
ScWRS in the presence of the DHFR_V10Amber
plasmid. Full-length DHFR with a C-terminal histidine
tag was isolated by IMAC, yielding 270mgs/l DHFR for
AS3.4 or 260mgs/l DHFR for AS3.5 [roughly two-thirds
the yield from the construct lacking the amber (TAG) stop
codon (pACYCSolo-DHFR-wt)].
However, as can be seen in Figure 8A, the AS3.5 sup-
pressor still produces a faint DHFR band on a
Coomassie-stained gel. Concentration of these protein
samples cells that only contained the suppressor tRNA
clearly reveals that DHFR is still being expressed in the
presence of the AS3.5 suppressor but not the AS3.4 sup-
pressor (93-fold concentration; Figure 8B). N-terminal
peptide sequencing of the DHFR samples isolated from
the strains expressing the AS3.4 and the AS3.5 suppres-
sors with the ScWRS revealed that both incorporate tryp-
tophan in DHFR in response to the amber nonsense
codon at position 10 (Figure 8C and D). However,
N-terminal sequencing of the DHFR band from the
AS3.5 suppressor-only sample revealed that lysine was
still being misincorporated at a low level by the
Sc-tRNA
Trp-AS3.5 suppressor (Figure 8E).
Pathways for the acquisition of suppressor activity
Several functional patterns emerge from these results. If
the anticodon stem contains the G27-C43/C28-G42 pairs,
the suppressors are non-functional (see variants AS.1 and
AS3.1). If the anticodon stem contains the G31-C39 base
pair, these tRNAs are functional but show varying levels
of background suppression (see variants AS3.2, AS3.3 and
AS3.6). If the base of the anticodon stem contains the
C31-G39 base pair, the tRNA demonstrates reduced back-
ground suppression levels (see variants AS2, AS3.4
and AS3.5).
The contributions of individual base pairs towards
charging and orthogonality can be better determined by
comparing individual variants (Figure 9). Starting with
the inactive AS1 variant, if the C28-G42 base pair is
changed to G28-C42 base pair found in variant AS3.2, a
signiﬁcant restoration of suppression activity is restored in
the presence of ScWRS ( 93.2U/mg of b-galactosidase
activity) but an increase in the background from AS1 is
also seen ( 2.2U/mg).
Continuing to compare substitutions, if the G31-C39
base pair at the base of the stem in variant AS3.2 is
then changed to C31-G39 to yield variant AS3.4, we
lose most of the background activity seen in AS3.2
(  1.9U/mg) but gain a small amount of activity
( 8.1U/mg) in the presence of ScWRS. A similar effect
is seen if we go from variant AS1 to AS3.1 and then to
AS3.4. If the G31-C39 base pair in AS1 is ﬁrst changed
to the C31-G39 base pair to yield variant AS3.1, only
a modest gain in activity is seen ( 0.5U/mg) but the
suppressor remains largely inactive and produces a
white colony in the spotting assay with or without the
ScWRS. When the C28-G42 base pair in AS3.1 is ﬁnally
changed to G28-C42 to yield variant AS3.4, there is a
quite signiﬁcant gain in suppression activity in the
presence of the ScWRS ( 100.8U/mg) but little in
the way of background activity ( 0.1U/mg). In other
words, both mutational routes from AS1 to AS3.4 yield
sequence intermediates whose activities can be readily
rationalized.
We can also calculate the contribution of the G27-C43
base pair to suppression activity by comparing the activity
of variant AS2 with variant AS3.4. In this case, the
C27-G43 base pair at the top of the acceptor stem in
AS2 is changed to a G27-C43 base pair found in AS3.4,
and this more than doubles the activity of the suppressor
with ScWRS ( 57.3U/mg), while reducing the back-
ground at the same time (  0.4U/mg).
Overall from these results, it is apparent that the
G28-C42 base pair is responsible for increasing the
overall activity of the suppressor, but especially the
Nucleic Acids Research, 2010, Vol.38, No. 19 6823activity associated with the ScWRS. The G27-C43 base
pair not only contributes to the overall activity of the sup-
pressor in the presence of the ScWRS, but also contributes
in part to reducing the background activity associated
with the E. coli KRS. The C31-G39 base pair does not
contribute greatly to the overall activity of the suppressor
with the ScWRS, but is the main contributor to the reduc-
tion of background activity with the E. coli KRS. It is
remarkable that these contributions are apparently
modular, and not highly context-dependent.
Figure 7. Suppression activity of optimized, rational suppressor tRNA mutants. (A) Mutant tRNA anticodon stem structures with mutations shown
in red or cyan. (B) b-galactosidase colony spot activity assay. Each mutant tRNA was expressed with (+) or without ( ) the ScWRS to test for
orthogonality. Each sample was taken from the same culture and spotted in triplicate in column format. (C) Quantitation of suppression activity with
b-galactosidase. Error bars represent 1 SD (n=3).
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One of the requirements for developing an orthogonal
aaRS -tRNA pair is that the tRNA works independently
of the host aaRSs and tRNAs. This means that the tRNA
must not interact with the endogenous aaRSs because this
could result in the insertion of more than one amino acid
at a given codon. The aaRS -tRNA recognition is
governed by interactions between a given aaRS and
identity elements on its cognate, the so-called ‘second
genetic code’. These interactions are not only unique to
each pair, but also typically exhibit species-speciﬁc differ-
ences, as well, which is one reason that heterologous pairs
can often be engineered to function as orthogonal pairs
(40). In the case of tryptophanyl tRNAs, the relevant
identity elements are thought to be discriminator bases
at position 73, either A73 in bacteria or G73 in eukaryotes
(40,51).
In order to introduce multiple unnatural amino acids
into proteins and whole organisms, it will be useful to
have multiple orthogonal tRNA synthetase:tRNA pairs.
In particular, we have previously attempted to evolve
E. coli to completely utilize the unnatural amino acid
4-ﬂuorotryptophan (20). Insights from these experiments
revealed that ‘top-down’ evolution of an organism’s
genetic code is not a practical approach to augment the
encoded amino acid content of proteins in a living cell
(52). These efforts were only partially successful, owing
in part to the fact that we did not attempt to pre-engineer
the aaRS -tRNA constituents of the cell. Over the last
decade, several groups have demonstrated the utility of
using mutated or evolved aaRSs and their cognate
tRNAs to expand the genetic code and add additional
amino acids into proteins (2,53). These ‘bottom-up’
approaches to evolving the genetic code when combined
with the cellular adaptation protocols used in the
‘top-down’ approaches may some day lead to artiﬁcial
cells that have refracted genetic codes which simultaneous-
ly encode for multiple unnatural amino acids (52). In
order to expand the amino acid diversity of a cell,
multiple distinct aaRS–tRNA orthogonal pairs will be
Figure 8. Verifying the orthogonality of AS3.4 and AS3.5. (A) Coomassie stained SDS–PAGE gel of IMAC puriﬁed DHFR expressed with and
without ScWRS and with the AS3.4 or the AS3.5 suppressor reveals that low level background suppression (AS3.5 suppressor tRNA without
ScWRS) still occurs with AS3.5. (B) Concentration of the suppressor tRNA-only (expressed from plasmid pBRIVTC3B) samples conﬁrms the
presence of the 18.7kDa DHFR band in the AS3.5 fraction, but not the AS3.4 fraction. The lane next to the marker is wild-type DHFR run with no
additional concentration. The elution fractions from IMAC columns for AS3.4 and AS3.5 expressed without ScWRS but with plasmid
pACYCSOLO-DHFR_V10Amb were concentrated and run on the gel at fractions representing concentration factors of 6.2-, 15.5-, 31-, 62- and
93-fold over the initially isolated protein concentration (Top panel). Western blot probing of the C-terminal HisTag on DHFR by a primary
AP-conjugated anti-polyhistidine antibody conﬁrms that DHFR is expressed at low levels in the AS3.5 sample but not in the AS3.4 sample (Bottom
panel). N-terminal sequencing of the puriﬁed DHFR samples reveals that both incorporate tryptophan when the ScWRS is co-expressed with the
suppressor tRNA (C and D). However, the AS3.5 suppressor is also misacylated by the E. coli KRS when expressed by itself (E).
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unnatural amino acids while maintaining the selectivity of
the translation process. To date, there are relatively few
orthogonal tRNA synthetase:tRNA pairs available for use
in E. coli, therefore in order to generate an ‘unColi’ with
an alternative genetic code and a proteome that is com-
pletely augmented with an unnatural amino acid, we have
developed a new orthogonal tRNA synthetase:tRNA pair
based on the S. cerevisiae WRS and tRNA.
We chose the WRS and its cognate tRNA as a starting
point for constructing an orthogonal pair due to a number
of features which make it particularly attractive for poten-
tially adding unnatural amino acids into proteins. These
features include the lack of an editing domain in the WRS
and its capacious binding pocket for the largest natural
amino acid which has previously led to its use for
incorporating tryptophan analogs into proteins (16,17).
The expanded substrate ﬂexibility of WRS has even sup-
ported adaptive evolution of whole bacteria and bacteria
phage proteomes to tryptophan analogs (18–20).
However, the engineering of the WRS (and its cognate
tRNA) for the site-speciﬁc insertion of large, heterocyclic
unnatural amino acids has not been sufﬁciently explored,
especially when compared with commonly used tyrosyl
tRNA synthetase (54). Zhang et al. (21) have used the
WRS from E. coli and an opal (TGA) nonsense suppres-
sor version of its cognate tRNA for the site-speciﬁc in-
corporation of 5-hydroxytryptophan into proteins in
mammalian cells, but this orthogonal pair cannot be
used in E. coli since it is of bacterial origin and has
Figure 9. Dissecting the contribution of mutations to suppressor activity. Anticodon representations of the designed suppressors are shown with the
mutations made in the ﬁrst and second round of designs shown in red and cyan, respectively. Grey spheres represent positions unchanged from the
original Sc-tRNA
Trp
Amb suppressor. The suppressor activities were calculated from the average values obtained from the b-galactosidase assay.
The top numbers (black) represent the change in activity between any two variants in the presence of the ScWRS. The bottom number (red)
represents the change in the background suppressor activity (tRNA only) between any two variants. The boxed values are the raw averaged
suppressor activities obtained for each variant, with the top number representing the activity with the ScWRS and the bottom number the
activity without the ScWRS.
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thogonality. Additionally, screening of synthetic sup-
pressor tRNAs from E. coli has revealed that the
tRNA
Trp is the most efﬁcient tRNA for incorporating
large unnatural amino acids such as ﬂuorophores into
proteins in E. coli in vitro (55,56). Therefore, we sought
to develop an orthogonal tryptophanyl pair for use in the
E. coli genetic background.
We anticipated that the yeast tryptophanyl tRNA
would be orthogonal to E. coli WRS based upon known
differences relative to the E. coli tRNA
Trp (22,23). The
conversion of the CCA anticodon sequence to CUA to
make an amber nonsense suppressor was also expected
to further enhance the anti-discrimination of the E. coli
WRS for the yeast tRNA
Trp
Amb, as this mutation in the
E. coli tRNA
Trp changes its identity from tryptophan to
glutamine (24). However, when the yeast tRNA
Trp
Amb was
initially expressed in E. coli, it was shown to be functional
but not orthogonal to the E. coli translational system
(Figure 2). Further analysis revealed that EcKRS was
responsible for the misacylation of the original
Sc-tRNA
Trp
Amb suppressor in the absence of the ScWRS
(Figure 3C). The misacylation of amber suppressor
tRNAs by the EcKRS is a widely reported phenomenon,
so much so that nearly a third of the amber suppressors
derived from different E. coli tRNAs (Ile, Arg, Met
(elongation), Asp, Val) all encode lysine in vivo (57).
Other amber suppressors including those derived from
the yeast tRNAs for phenylalanine (7), isoleucine (50)
and tyrosine (43) have also been shown to be misacylated
by the EcKRS in vivo.
The major identity elements of the Ec-tRNA
Lys have
been previously determined to be the anticodon nucleo-
tides mnm
5s
2U34, U35, U36 and the discriminator nucleo-
tide A73 (38,39). Since EcKRS can bind the mnm
5s
2U34
modiﬁed nucleotide or cytosine equally well this means
that three of the four major identity elements are shared
between the yeast tRNA
Trp
amb suppressor and
Ec-tRNA
Lys (Figure 4). Making mutations in the anti-
codon stems of amber suppressor tRNAs derived from
the yeast phenylalanine, tyrosine and isoleucine, tRNAs
has been previously reported to reduce the mischarging of
the suppressor tRNAs by the EcKRS (7,43,50). Fukunaga
et al. (43) reported that G-C enrichment of the anticodon
stem of Sc-tRNA
Tyr
Amb led to signiﬁcant reduction in
misacylation by EcKRS. Based on these ﬁndings, these
authors hypothesized that the interaction between
EcKRS and Ec-tRNA
Lys requires a structural element in
the anticodon stem which provides ﬂexibility during the
aaRS/tRNA recognition process (44). G-C enrichment of
the anticodon stem presumably reduces its ﬂexibility and
thereby reduces its interaction with EcKRS. This hypoth-
esis is anecdotally supported by comparison of the
anti-codon stems of all of the known E. coli orthogonal
tRNAs (Supplementary Figure S3), all of which have rela-
tively G-C rich anticodon stems. In comparison, the
tRNA
Trp
Amb contains an A-U rich anticodon stem,
much like the Ec-tRNA
Lys.
Building on these ﬁndings, we made a series of anti-
codon stem mutations in Sc-tRNA
Tyr
Amb aimed at dis-
rupting the structural plasticity of this stem and thus the
aberrant interaction with EcKRS. In order to better parse
out the individual effects of G-C substitutions, 16 different
Sc-tRNA
Tyr
Amb anticodon stem mutants were made and
screened via a b-galactosidase suppression assay. Of these
16 mutants, one variant, AS3.4, demonstrated a complete-
ly orthogonal phenotype. This variant contained a highly
G-C enriched anticodon stem (G28-C42, C31-G39 and
G27-C43). The G28-C42 and G27-C43 base pairs at the
top of the anticodon stem were found to enhance suppres-
sion activity in the presence of the ScWRS, while the
C31-G39 base pair at the bottom of the anticodon stem
led to the greatest reduction in background suppression by
EcKRS (Figure 9). In agreement with these results, this
latter mutation has also been shown to reduce the
mischarging of the yeast tRNA
Tyr by EcKRS (44).
Interestingly, the C31-G39 base pair in yeast
tRNA
Tyr
Amb also led to an increase in misacylation by
E. coli glutamine tRNA synthetase. This result was
similar to the results reported by Normanly et al. (57)
two decades ago for amber suppressors derived from
two isoacceptors for E. coli tRNA
Ile. In this case, when
tRNA
Ile
1 was made into an amber suppressor it was
aminoacylated with glutamine, whereas the tRNA
Ile
2
amber suppressor was charged with lysine. One of the
sequence differences between these two tRNA
Ile
isoacceptors was the 31–39 base pair which was
C31-G39 in tRNA
Ile
1 and A31-39 for tRNA
Ile
2, conﬁrm-
ing the importance of the C31-G39 base pair for
anti-discrimination by the EcKRS. These results suggest
that the EcKRS could utilize a tRNA recognition and
catalysis mechanism similar to the arginyl-tRNA
synthetase which requires some ﬂexibility in its cognate
tRNA to undergo its induced-ﬁt mode of catalysis (58).
The reduction in the ﬂexibility of the anticodon stem in
mutant AS3.4 may have abolished recognition by the
EcKRS.
Unfortunately, the previous attempts to rationally
design an orthogonal suppressor tRNA based on the
yeast tRNA
Tyr were ultimately unsuccessful, even
though the methodology was similar to that reported
herein. This could be due to subtle structural differences
between the engineered yeast tRNA
Tyr anticodon stem
relative to the engineered yeast tRNA
Trp anticodon
stem, as none of the mutants assayed were identical.
That said, the most orthogonal tRNA
Tyr suppressor that
was reported had an anticodon stem sequence that was
very similar to our AS3.5 tRNA
Trp variant, differing at
only a single base pair (G29-C41 for the tRNA
Tyr variant
versus C29-G41 for AS3.5).
It is especially interesting that the impact of individual
G-C substitutions on both charging by the ScWRS and
mischarging by the Ec-LysRS appeared to be modular and
additive (Figure 9). This was not necessarily to have been
expected, since many protein:RNA interactions require
precise conformational ﬁts in which any perturbation
will signiﬁcantly decrease afﬁnity and activity. The
apparent additivity of the interactions implies that it
may be possible in the future to rationally engineer the
ﬂexibility of tRNAs to achieve novel speciﬁcities. More
intriguingly, these results suggest how changes in the
genetic code may have evolved. Changes in tRNA
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genetic code, with new amino acids being lost or acquired
at particular codons. However, additional mutations in
tRNAs that lead to ambiguous charging speciﬁcities
could modulate the adoption of a new code, moving
through an intermediate state in which more than one
amino acid was proportionately introduced across from
a given codon (59–61). The fact that changes in stem ﬂexi-
bility can gradually and additively lead to alterations in
this ambiguity (in ‘mischarging’) implies that evolutionary
routes to new codes could lead gradually through ambigu-
ously recoded proteomes.
Previously reported reﬁnements of orthogonal suppres-
sor tRNAs were largely done by directed evolution from a
library of mutations that tended to focus any mutations
made from a proposed suppressor in the acceptor stem (4),
or the loop regions of the tRNA sequence (62) to screen
for mutations that enhanced the orthogonal character of a
mutant tRNA. These regions of the tRNA are logical
starting points for incorporating additional discrimination
elements into tRNAs as these regions are commonly
accessed by aaRSs. However, in light of the results pre-
sented herein, modiﬁcation of the structural features of
tRNAs should also be considered when designing/
evolving aaRS interactions. Due to tRNA’s central role
in the translation system, tRNA molecules have to interact
with multiple proteins (aaRSs, EFTu) and the ribosome
itself. The evolved ﬂexibility of the tRNA molecule
enables it to interact with multiple binding partners
making this feature of tRNAs one of the most essential
for translation (63). While interactions between tRNA
identity elements and aaRSs (64), and between the
tRNA acceptor stem and EFTu (65) have been extensively
explored, the role of structural ﬂexibility in ﬁne-tuning
these interactions is still largely unknown. Recent and
future molecular dynamic simulations of tRNAs during
translation will hopefully help to illuminate this largely
overlooked property of tRNAs (63). In this regard,
mutant tRNAs such as those reported herein could be
useful for studying the structural dynamics of tRNA inter-
actions between cognate and non-cognate aaRSs, much as
the Hirsh suppressor tRNA
Trp (66) was useful for
decoding the dynamics of codon–anticodon interactions
on the ribosome (67).
The Sc-tRNA
Trp-AS3.4 and ScWRS orthogonal pair
reported herein is to our knowledge the only reported
tryptophanyl-based orthogonal pair available for use in
prokaryotes and should be of great use in expanding
efforts to evolve proteins that contain unnatural amino
acids. In addition to potentially being used for changing
the genetic code of a cell, this orthogonal suppressor
system could also be used for recoding in vitro. For
example, recombinant translation systems [similar to the
PURE system (68)] have been used by Forster and col-
leagues (69,70) to introduce chemically acylated tRNAs
containing unnatural amino acids into peptides.
Similarly, Szostak and colleagues (71,72) have made
peptides containing multiple unnatural amino acid
analogs by taking advantage of the natural substrate ﬂexi-
bility of aaRSs. In either instance, the new orthogonal pair
could be introduced in place of tRNA synthetase and its
cognate tRNA, or in addition to the standard complement
of synthetases and tRNAs in order to more efﬁciently
generate proteins with altered compositions.
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